Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Flaminia Coluzzi, Francesca Felicia Caputi, Domenico Billeci, Antonio Luigi Pastore, Sanzio Candeletti, Monica Rocco & Patrizia Romualdi. (2020) Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists. Therapeutics and Clinical Risk Management 16, pages 821-837.
Read now
Read now
Joseph V. Pergolizzi$suffix/text()$suffix/text(), Jo Ann LeQuang, Robert Taylor$suffix/text()$suffix/text(), Michael H. Ossipov, Daniel Colucci & Robert B. Raffa. (2018) Designing safer analgesics: a focus on μ-opioid receptor pathways. Expert Opinion on Drug Discovery 13:10, pages 965-972.
Read now
Read now
Gerhard Müller-Schwefe, Bart Morlion, Karsten Ahlbeck, Eli Alon, Stefano Coaccioli, Flaminia Coluzzi, Frank Huygen, Wolfgang Jaksch, Eija Kalso, Magdalena Kocot-Kępska, Hans-Georg Kress, Ana Cristina Mangas, Cesar Margarit Ferri, Philippe Mavrocordatos, Andrew Nicolaou, Concepción Pérez Hernández, Joseph Pergolizzi, Michael Schäfer & Patrick Sichère. (2017) Treatment for chronic low back pain: the focus should change to multimodal management that reflects the underlying pain mechanisms. Current Medical Research and Opinion 33:7, pages 1199-1210.
Read now
Read now
Nikolaos Papanas & Dan Ziegler. (2016) Emerging drugs for diabetic peripheral neuropathy and neuropathic pain. Expert Opinion on Emerging Drugs 21:4, pages 393-407.
Read now
Read now
Articles from other publishers (28)
Shikha Choudhary, Raminderjit Kaur, Aafrin Waziri, Arun Garg, Renu Kadian & Md Sabir Alam. (2023) N-type calcium channel blockers: a new approach towards the treatment of chronic neuropathic pain. Exploration of Medicine, pages 85-106.
Crossref
Crossref
Shivangi Patel, Hasnat Khan & Anuradha Majumdar. (2022) Crosstalk between Sirtuins and Nrf2: SIRT1 activators as emerging treatment for diabetic neuropathy. Metabolic Brain Disease 37:7, pages 2181-2195.
Crossref
Crossref
Levent HACISÜLEYMAN, Bülent SARAÇ & Ziad JOHA. (2022) Analgesic Effects of Vilazodone, Indatraline, and Talsupram in a Rat Model of Neuropathic Pain. Turkish Journal of Pharmaceutical Sciences 19:3, pages 336-342.
Crossref
Crossref
Irfat Ara & Mudasir Maqbool. (2022) The curious case of Neuropathic Pain and its management: An overview. Open Health 3:1, pages 145-154.
Crossref
Crossref
Gordon Sloan, Dinesh Selvarajah & Solomon Tesfaye. (2021) Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nature Reviews Endocrinology 17:7, pages 400-420.
Crossref
Crossref
Md. Tanvir Kabir, Nuzhat Tabassum, Md. Sahab Uddin, Faissal Aziz, Tapan Behl, Bijo Mathew, Md. Habibur Rahman, Raushanara Akter, Abdur Rauf & Lotfi Aleya. (2021) Therapeutic Potential of Polyphenols in the Management of Diabetic Neuropathy. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-20.
Crossref
Crossref
Qiaoyun Wu, Jingjing Yue, Li Lin, Xiaolan Yu, Ye Zhou, Xinwang Ying, Xiaolong Chen, Wenzhan Tu, Xinfa Lou, Guanhu Yang, Kecheng Zhou & Songhe Jiang. (2021) Electroacupuncture may alleviate neuropathic pain via suppressing P2X7R expression. Molecular Pain 17, pages 174480692199765.
Crossref
Crossref
Wen-jun Zhang, Hong-liang Luo & Zheng-ming Zhu. (2020) The role of P2X4 receptors in chronic pain: A potential pharmacological target. Biomedicine & Pharmacotherapy 129, pages 110447.
Crossref
Crossref
Wen-Jun Zhang, Zheng-Ming Zhu & Zeng-Xu Liu. (2020) The role of P2X4 receptor in neuropathic pain and its pharmacological properties. Pharmacological Research 158, pages 104875.
Crossref
Crossref
Uazman Alam, Gordon Sloan & Solomon Tesfaye. (2020) Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs. Drugs 80:4, pages 363-384.
Crossref
Crossref
Wen-jun Zhang, Zheng-ming Zhu & Zeng-xu Liu. (2020) The role and pharmacological properties of the P2X7 receptor in neuropathic pain. Brain Research Bulletin 155, pages 19-28.
Crossref
Crossref
David M. Walton, Stephen D. Minton & Alonzo D. Cook. (2019) The potential of transdermal nitric oxide treatment for diabetic peripheral neuropathy and diabetic foot ulcers. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13:5, pages 3053-3056.
Crossref
Crossref
Abhijit Das & Hindol Mondal. (2017) Pharmacotherapy of Neuropathic Pain. Bengal Physician Journal 6:2, pages 28-30.
Crossref
Crossref
Zahra Bahari & Gholam Hossein Meftahi. (2019)
Spinal α
2
‐adrenoceptors and neuropathic pain modulation; therapeutic target
. British Journal of Pharmacology 176:14, pages 2366-2381.
Crossref
Crossref
Shazli Azmi, Ioannis N. Petropoulos, Maryam Ferdousi, Georgios Ponirakis, Uazman Alam & Rayaz A. Malik. (2019) An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy. F1000Research 8, pages 186.
Crossref
Crossref
Eugenio Cavalli, Santa Mammana, Ferdinando Nicoletti, Placido Bramanti & Emanuela Mazzon. (2019) The neuropathic pain: An overview of the current treatment and future therapeutic approaches. International Journal of Immunopathology and Pharmacology 33, pages 205873841983838.
Crossref
Crossref
Shazli Azmi, Maryam Ferdousi, Alise Kalteniece, Hamad Al-Muhannadi, Abdulrahman Al-Mohamedi, Nebras H. Hadid, Salah Mahmoud, Harun A. Bhat, Hoda Y. A. Gad, Adnan Khan, Georgios Ponirakis, Ioannis N. Petropoulos, Uazman Alam & Rayaz A. Malik. (2019) Diagnosing and managing diabetic somatic and autonomic neuropathy. Therapeutic Advances in Endocrinology and Metabolism 10, pages 204201881982689.
Crossref
Crossref
F. Coluzzi, D. Billeci, M. Maggi & G. Corona. (2018) Testosterone deficiency in non-cancer opioid-treated patients. Journal of Endocrinological Investigation 41:12, pages 1377-1388.
Crossref
Crossref
Yingchao Li, Yongjun Wang, Ran Zhang, Cuiru Liu, Yue Wei, Jin Sun, Zhonggui He, Youjun Xu & Tianhong Zhang. (2018) Improving the oral bioavailability of tapentadol via a carbamate prodrug approach: synthesis, bioactivation, and pharmacokinetics. Drug Delivery and Translational Research 8:5, pages 1335-1344.
Crossref
Crossref
Emma Partridge, Eric Teoh, Christine Nash, Timothy Scott, Cheryl Charlwood & Chris Kostakis. (2018) The Increasing Use and Abuse of Tapentadol and Its Incorporation Into a Validated Quantitative Method. Journal of Analytical Toxicology 42:7, pages 485-490.
Crossref
Crossref
Sonia Torres-Sanchez, Gisela Da Silva Borges, Juan A. Mico & Esther Berrocoso. (2018) Opioid and noradrenergic contributions of tapentadol to the inhibition of locus coeruleus neurons in the streptozotocin rat model of polyneuropathic pain. Neuropharmacology 135, pages 202-210.
Crossref
Crossref
L. Arendt‐Nielsen, B. Morlion, S. Perrot, A. Dahan, A. Dickenson, H.G. Kress, C. Wells, D. Bouhassira & A. Mohr Drewes. (2017) Assessment and manifestation of central sensitisation across different chronic pain conditions. European Journal of Pain 22:2, pages 216-241.
Crossref
Crossref
George W. Young & Michael J. Mehnert. 2018. Challenging Neuropathic Pain Syndromes. Challenging Neuropathic Pain Syndromes
53
64
.
Diego Fornasari. (2017) Pharmacotherapy for Neuropathic Pain: A Review. Pain and Therapy 6:S1, pages 25-33.
Crossref
Crossref
Edvina Galiè, Veronica Villani, Irene Terrenato & Andrea Pace. (2017) Tapentadol in neuropathic pain cancer patients: a prospective open label study. Neurological Sciences 38:10, pages 1747-1752.
Crossref
Crossref
Joseph V PergolizziJrJr, Frank Breve, Robert TaylorJrJr, Robert B Raffa, Stephani E Strasburger & Jo Ann LeQuang. (2017) Considering tapentadol as a first-line analgesic: 14 questions. Pain Management 7:4, pages 331-339.
Crossref
Crossref
Nalini Vadivelu, Daniel Chang, Erik M. Helander, Gregory J. Bordelon, Alice Kai, Alan D. Kaye, Dora Hsu, Daniel Bang & Inderjeet Julka. (2017) Ketorolac, Oxymorphone, Tapentadol, and Tramadol. Anesthesiology Clinics 35:2, pages e1-e20.
Crossref
Crossref
Christian Elling, Maja Galic & Ilona Steigerwald. (2015) Tapentadol prolonged release in the treatment of neuropathic pain related to diabetic polyneuropathy. The Lancet Neurology 14:7, pages 684-685.
Crossref
Crossref